Cargando…
Rare ROS1-CENPW gene in pancreatic acinar cell carcinoma and the effect of crizotinib plus AG chemotherapy: A case report
BACKGROUND: This is the first report of an ROS1-CENPW fusion gene in pancreatic malignancies. CASE SUMMARY: A 77-year-old woman with a pancreatic tumor and multiple liver metastases was admitted to our hospital. Genetic testing revealed the presence of the ROS1-CENPW fusion gene, a rare fusion gene...
Autores principales: | Wang, Tao, Shen, Yi-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506013/ https://www.ncbi.nlm.nih.gov/pubmed/37727713 http://dx.doi.org/10.12998/wjcc.v11.i24.5823 |
Ejemplares similares
-
Knockdown of CENPW Inhibits Hepatocellular Carcinoma Progression by Inactivating E2F Signaling
por: Zhou, Yajing, et al.
Publicado: (2021) -
Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma
por: Wang, Luyang, et al.
Publicado: (2022) -
Acinar Cell Carcinoma: A Rare Pancreatic Malignancy
por: Chaudhary, Poras, et al.
Publicado: (2013) -
Pancreatic Acinar Cell Carcinoma
por: Béchade, Dominique, et al.
Publicado: (2016) -
Efficacy of crizotinib and pemetrexed-based chemotherapy in Chinese NSCLC patients with ROS1 rearrangement
por: Zhang, Limin, et al.
Publicado: (2016)